Skip to main content

Table 2 Risk factors for HBeAg positivity

From: Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study

  N Odds ratio univariable analysis p-value Odds ratio multivariable analysis p-value
Sex 391     
Female 170 1 0.61   
Male 221 1.12 (0.71–1.78)    
Age 391 0.98 (0.97–0.99) 0.04 0.98 (0.96–0.99) 0.02
Genotype 391     
A 67 1   1  
B 31 0.96 (0.38–2.45) 0.93 0.79 (0.23–2.65) 0.70
C 36 2.63 (1.14–6.07) 0.02 1.99 (0.67–5.91) 0.22
D 222 0.77 (0.42–1.42) 0.41 1.57 (0.70–3.54) 0.28
E 28 0.94 (0.36–2.49) 0.90 1.37 (0.35–5.35) 0.64
F 7 3.13 (0.64–15.30) 0.16 4.11 (0.73–23.10) 0.11
Region of origin 391     
Switzerland 63 1   1  
Europe and Mediterranean 161 0.34 (0.18–0.66) 0.01 0.24 (0.10–0.57) 0.01
Sub-Saharan Africa 39 0.64 (0.27–1.51) 0.31 0.42 (0.11–1.53) 0.19
Asia 89 1.27 (0.66–2.45) 0.48 1.03 (0.41–2.58) 0.94
Unknown and Other 39 0.81 (0.35–1.88) 0.63 0.53 (0.20–1.40) 0.20
HIV Status 228   0.03   0.11
HIV positive 15 4.51 (1.45–14.01)   2.53 (0.82–7.84)  
  1. 95 % Conf. Interval in brackets; HIV Human Immunodeficiency virus